S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I. (Ad)
Nigeria's central bank chief arrested after being suspended by president
Closing prices for crude oil, gold and other commodities
NASDAQ:DCPH

Deciphera Pharmaceuticals (DCPH) News Today

$14.02
+0.04 (+0.29%)
(As of 06/9/2023 ET)
Compare
Today's Range
$13.67
▼
$14.10
50-Day Range
$13.28
▼
$15.96
52-Week Range
$10.14
▼
$22.76
Volume
627,585 shs
Average Volume
444,266 shs
Market Capitalization
$1.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.78
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
Get Deciphera Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for DCPH and its competitors with MarketBeat's FREE daily newsletter.



DCPH Media Mentions By Week

DCPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DCPH
News Sentiment
▼
1.15

0.87
▲
Average
Medical
News Sentiment

DCPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DCPH Articles
This Week
▼
5

2
▲
DCPH Articles
Average Week

SourceHeadline
finance.yahoo.com logoCalculating The Intrinsic Value Of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
finance.yahoo.com - June 9 at 10:24 AM
marketbeat.com logoMartingale Asset Management L P Purchases 28,059 Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
marketbeat.com - June 6 at 7:55 AM
MarketBeat logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives $21.78 Consensus PT from Brokerages
americanbankingnews.com - June 6 at 1:20 AM
msn.com logoJMP Securities Reiterates Deciphera Pharmaceuticals (DCPH) Market Outperform Recommendation
msn.com - June 5 at 3:26 PM
marketbeat.com logoCitigroup Inc. Lowers Stock Holdings in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
marketbeat.com - May 26 at 5:37 AM
MarketBeat logoEquities Analysts Offer Predictions for Deciphera Pharmaceuticals, Inc.'s Q2 2023 Earnings (NASDAQ:DCPH)
americanbankingnews.com - May 20 at 2:22 AM
MarketBeat logoDeciphera Pharmaceuticals (NASDAQ:DCPH) Stock Price Up 7.8% After Insider Buying Activity
americanbankingnews.com - May 17 at 1:10 AM
marketbeat.com logoSG Americas Securities LLC Has $156,000 Stock Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
marketbeat.com - May 14 at 4:20 AM
MarketBeat logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Given Average Rating of "Moderate Buy" by Analysts
americanbankingnews.com - May 14 at 2:50 AM
marketbeat.com logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Director Dennis Leo Walsh Buys 11,000 Shares
marketbeat.com - May 12 at 5:48 PM
MarketBeat logoHC Wainwright Weighs in on Deciphera Pharmaceuticals, Inc.'s FY2023 Earnings (NASDAQ:DCPH)
americanbankingnews.com - May 9 at 4:18 AM
marketbeat.com logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives Average Rating of "Moderate Buy" from Analysts
marketbeat.com - May 9 at 3:20 AM
MarketBeat logoQ2 2023 EPS Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Decreased by Analyst
americanbankingnews.com - May 9 at 2:38 AM
markets.businessinsider.com logoJonesTrading Remains a Hold on Deciphera Pharmaceuticals (DCPH)
markets.businessinsider.com - May 8 at 4:15 PM
marketbeat.com logoDeciphera Pharmaceuticals, Inc. Forecasted to Post FY2023 Earnings of ($2.59) Per Share (NASDAQ:DCPH)
marketbeat.com - May 8 at 3:36 AM
MarketBeat logoStifel Nicolaus Trims Deciphera Pharmaceuticals (NASDAQ:DCPH) Target Price to $14.00
americanbankingnews.com - May 7 at 7:10 AM
seekingalpha.com logoDeciphera Pharmaceuticals, Inc. (DCPH) Q1 2023 Earnings Call Transcript
seekingalpha.com - May 7 at 4:58 AM
benzinga.com logoDeciphera Pharmaceuticals Stock (NASDAQ:DCPH), Dividends
benzinga.com - May 5 at 12:13 PM
marketbeat.com logoFY2026 EPS Estimates for Deciphera Pharmaceuticals, Inc. Decreased by Analyst (NASDAQ:DCPH)
marketbeat.com - May 5 at 8:27 AM
MarketBeat logoDeciphera Pharmaceuticals (NASDAQ:DCPH) Announces Quarterly Earnings Results
americanbankingnews.com - May 5 at 7:26 AM
MarketBeat logoDeciphera Pharmaceuticals (NASDAQ:DCPH) Shares Gap Down to $14.30
americanbankingnews.com - May 5 at 6:02 AM
finance.yahoo.com logoDeciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 3 at 2:16 PM
msn.com logoRecap: Deciphera Pharmaceuticals Q1 Earnings
msn.com - May 3 at 8:43 AM
finance.yahoo.com logoDeciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
finance.yahoo.com - May 3 at 8:43 AM
markets.businessinsider.com logoWhat Wall Street expects from Deciphera Pharmaceuticals's earnings
markets.businessinsider.com - May 2 at 6:26 PM
MarketBeat logoSVB Leerink Equities Analysts Cut Earnings Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
americanbankingnews.com - April 28 at 6:32 AM
MarketBeat logoDeciphera Pharmaceuticals, Inc. to Post FY2025 Earnings of $0.26 Per Share, SVB Leerink Forecasts (NASDAQ:DCPH)
americanbankingnews.com - April 28 at 5:48 AM
finance.yahoo.com logoWill Deciphera Pharmaceuticals, Inc. (DCPH) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - April 26 at 1:55 PM
finance.yahoo.com logoDeciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023
finance.yahoo.com - April 26 at 8:54 AM
marketbeat.com logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Short Interest Up 6.9% in March
marketbeat.com - April 21 at 4:25 PM
finance.yahoo.com logoThere Is A Reason Deciphera Pharmaceuticals, Inc.'s (NASDAQ:DCPH) Price Is Undemanding
finance.yahoo.com - April 18 at 7:25 AM
MarketBeat logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives Average Rating of "Moderate Buy" from Brokerages
americanbankingnews.com - April 14 at 6:14 AM
marketbeat.com logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Given Average Recommendation of "Moderate Buy" by Analysts
marketbeat.com - April 14 at 6:13 AM
seekingalpha.com logoDeciphera Pharmaceuticals, Inc.(DCPH) Investor Presentation - Slideshow
seekingalpha.com - March 31 at 9:57 AM
seekingalpha.com logoDeciphera Pharmaceuticals: In The Middle Of A Major Comeback (Upgrade)
seekingalpha.com - March 27 at 2:46 PM
MarketBeat logoSteven L. Hoerter Sells 7,500 Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Stock
americanbankingnews.com - March 25 at 5:42 AM
marketbeat.com logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Shares Sold by Hennion & Walsh Asset Management Inc.
marketbeat.com - March 23 at 5:19 AM
MarketBeat logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives $22.22 Consensus Target Price from Brokerages
americanbankingnews.com - March 23 at 1:40 AM
marketbeat.com logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Given Consensus Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - March 20 at 4:25 AM
seekingalpha.com logoDeciphera Pharmaceuticals: INTRIGUE Phase 3 Shows Substantial Benefit
seekingalpha.com - March 18 at 5:21 AM
seekingalpha.com logoDeciphera Pharmaceuticals (DCPH) Investor Presentation - Slideshow
seekingalpha.com - March 17 at 3:00 PM
msn.com logoWhy Deciphera Pharmaceuticals Stock Jumped This Week
msn.com - March 16 at 6:16 PM
finance.yahoo.com logoDeciphera Pharmaceuticals, Inc. (DCPH) Soars 10.3%: Is Further Upside Left in the Stock?
finance.yahoo.com - March 14 at 7:01 AM
marketbeat.com logoJacobs Levy Equity Management Inc. Has $24.26 Million Stock Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
marketbeat.com - March 10 at 9:25 AM
finance.yahoo.com logoWhy Is Deciphera Pharmaceuticals, Inc. (DCPH) Down 7.1% Since Last Earnings Report?
finance.yahoo.com - March 9 at 3:15 PM
marketbeat.com logoNuveen Asset Management LLC Increases Stake in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
marketbeat.com - March 7 at 4:41 AM
finance.yahoo.com logoDeciphera Pharmaceuticals Announces Completion of Enrollment for Pivotal Phase 3 MOTION Study of Vimseltinib in TGCT
finance.yahoo.com - March 1 at 8:37 AM
marketbeat.com logoArmistice Capital LLC Has $88.21 Million Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
marketbeat.com - February 24 at 10:49 AM
marketbeat.com logoDeciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) EVP Sells $14,662.10 in Stock
marketbeat.com - February 17 at 4:18 PM
nasdaq.com logoBank Of America Now Owns 0.40% of Deciphera Pharmaceuticals (DCPH)
nasdaq.com - February 16 at 3:31 PM
Get Deciphera Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for DCPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:DCPH) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -